Detalhe da pesquisa
1.
Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients.
J Antimicrob Chemother
; 74(12): 3537-3545, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31651031
2.
Feasibility of Real Time Medication Monitoring Among HIV Infected and TB Patients in a Resource-Limited Setting.
AIDS Behav
; 20(5): 1097-107, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26604004
3.
Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settings.
Ther Drug Monit
; 37(1): 22-32, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24943062
4.
Concentrations of respirable crystalline silica and radon among tanzanite mining communities in Mererani, Tanzania.
Ann Work Expo Health
; 68(1): 48-57, 2024 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37824745
5.
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.
Antimicrob Agents Chemother
; 57(7): 3208-13, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23629715
6.
Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania.
PLoS One
; 18(3): e0280396, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920939
7.
Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania.
Pilot Feasibility Stud
; 9(1): 55, 2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005695
8.
Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania.
J Antimicrob Chemother
; 66(8): 1810-4, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21642290
9.
Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatment.
J Antimicrob Chemother
; 65(1): 145-7, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19900951
10.
Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial.
Trials
; 20(1): 426, 2019 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31300028
11.
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Lancet Infect Dis
; 17(1): 39-49, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28100438
12.
Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study.
Antivir Ther
; 18(1): 105-13, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23043067
13.
AtriplaR/anti-TB combination in TB/HIV patients. Drug in focus.
BMC Res Notes
; 4: 511, 2011 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22114934